Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2002-8-27
pubmed:abstractText
Mammalian mel-18 is a member of the polycomb group, and it acts as a transcriptional repressor with DNA binding activity. Murine mel-18 negatively regulates the cell cycle through the c-myc/cdc25 cascade, and mice haploinsufficient for mel-18 develop mammary gland tumors. In addition, the human homolog of mel-18 is located at 17q, on which candidate tumor suppressor genes for breast cancer have been suggested for a long time. These observations indicate that the mel-18 gene may be a tumor suppressor gene for breast cancer. To investigate this possibility, we examined the expression of mel-18 mRNA in human breast cancer cell lines and searched for mel-18 gene mutations in sporadic and familial breast cancers.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1340-6868
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
33-8
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:12196719-Adult, pubmed-meshheading:12196719-Aged, pubmed-meshheading:12196719-Breast Neoplasms, pubmed-meshheading:12196719-DNA Primers, pubmed-meshheading:12196719-DNA-Binding Proteins, pubmed-meshheading:12196719-Female, pubmed-meshheading:12196719-Gene Expression Regulation, Neoplastic, pubmed-meshheading:12196719-Genetic Predisposition to Disease, pubmed-meshheading:12196719-Humans, pubmed-meshheading:12196719-Loss of Heterozygosity, pubmed-meshheading:12196719-Middle Aged, pubmed-meshheading:12196719-Mutation, pubmed-meshheading:12196719-Polymerase Chain Reaction, pubmed-meshheading:12196719-Polymorphism, Single-Stranded Conformational, pubmed-meshheading:12196719-RNA, Messenger, pubmed-meshheading:12196719-Repressor Proteins, pubmed-meshheading:12196719-Tumor Cells, Cultured
pubmed:year
2002
pubmed:articleTitle
Mutation analysis of the mel-18 gene that shows decreased expression in human breast cancer cell lines.
pubmed:affiliation
Department of Molecular Diagnosis, Cancer Institute, Japanese Foundation for Cancer Research, 1-37-1 Kami-ikebukuro, Toshima-ku, Tokyo 170-8455, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't